Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability

Research Article - (2017) Volume 9, Issue 4

Policy Practices to Maximise Social Benefit from Biosimilars

Inotai A1,2*, Csanádi M1,3, Vitezic D4, Francetic I5, Tesar T6, Bochenek T7, Lorenzovici L8,9, Dylst P10 and Kaló Z1,2
1Syreon Research Institute, Budapest, Hungary
2Center for Expert Medicine, Zagreb, Croatia
3Department of Pharmaceutics and Central Clinical Pharmacy, University of Pécs, Pécs, Hungary
4University of Rijeka School of Medicine and University Hospital Centre Rijeka, Rijeka, Croatia
5Center for Expert Medicine, Zagreb, Croatia
6Department of Organisation and Management in Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia
7Department of Drug Management, Institute of Public Health, Jagiellonian University Medical College, Krakow, Poland
8Syreon Research Romania, Tirgu Mures, Romania
9Faculty of Technical and Human Sciences, Sapientia University, Tirgu Mures, Romania
10Biosimilar Medicines Group, Medicines for Europe, Brussels, Belgium
*Corresponding Author: